Erratum to metformin up-regulated miR-107 expression and enhanced the inhibitory effect of miR-107 on gastric cancer growth
Erratum to: Transl Cancer Res 2020;9:2941-50.
Metformin up-regulated miR-107 expression and enhanced the inhibitory effect of miR-107 on gastric cancer growth
In the April 2020 issue Vol 9, No 4 of Translational Cancer Research, the paper “Metformin up-regulated miR-107 expression and enhanced the inhibitory effect of miR-107 on gastric cancer growth”, 2020 Mar; 9(4): 2941-2950, by Yongyi Chen, Wangang Gong, and Yun Zhou et al. (1), was published with some errors and should be corrected as below:
- The dose of metformin “1.0 mmol/L” in Figure 2 legend should be corrected as “20 mM”.
- The microRNA name in Figure 3 legend was incorrect that “miR-34a” should be corrected as “miR-107”.
- In Y-axis of Figure 3D, “relative SGC-7901 proliferation” should be changed to “Expression of MAPK8”.
The authors regret the errors and all the inconveniences caused.
Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
References
- Chen Y, Gong W, Zhou Y, et al. Metformin up-regulated miR-107 expression and enhanced the inhibitory effect of miR-107 on gastric cancer growth. Transl Cancer Res 2020;9:2941-50. [Crossref]
